为什么临床开发策略应在 IND 申报前开始
IND submission is one of the most visible milestones in early drug development. But treating the IND as the starting […]
人工智能在临床开发中真正能够创造价值的地方
Artificial intelligence is rapidly becoming part of clinical development. But adoption alone does not create value. For sponsors, the more […]
全球业务拓展：为什么美国是首选
Did you know that foreign companies held over $5.39 trillion in direct investments in the U.S. by the end of […]